Enovis (ENOV) Amortization of Deferred Charges (2010 - 2011)
Enovis (ENOV) reported Amortization of Deferred Charges of $187000.0 for Q4 2011, up 10.65% year-over-year from $169000.0 in Q4 2010, and little changed on a QoQ basis from $187000.0 in Q3 2011.
Enovis (ENOV) has 2 years of Amortization of Deferred Charges data on file, last reported at $187000.0 in Q4 2011.
- Quarterly Amortization of Deferred Charges rose 10.65% year-over-year to $187000.0 in Q4 2011, while the trailing twelve-month figure through Dec 2011 was $713000.0 (changed N/A YoY) and the FY2011 annual result came in at $735000.0, up 8.57% from the prior year.
- Amortization of Deferred Charges held at $187000.0 in Q4 2011 per ENOV's latest filing, from $187000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $187000.0 in Q3 2011 and bottomed at $169000.0 in Q4 2010.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Enovis | 1.25 Bn | 1.22 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 187,000.00 |
| Dec 31, 2011 | 187,000.00 |
| Sep 30, 2011 | 187,000.00 |
| Sep 30, 2011 | 187,000.00 |
| Dec 31, 2010 | 169,000.00 |
| Dec 31, 2010 | 169,000.00 |
| Oct 1, 2010 | 170,000.00 |
| Oct 1, 2010 | 170,000.00 |